biomarker study

OTHER4 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Side-Out Foundation, University of Southampton, Elysium Health

Conditions

Colorectal CancerEpigeneticsMetastatic Breast CancerMolecular TaxonomyMuscle Invasive Bladder Cancer

Unknown Phase

Basal Like Bladder Cancer : Signature and Therapeutic

Assistance Publique - Hôpitaux de ParisMolecular Taxonomy, Muscle Invasive Bladder Cancer

Start: 2014-03-31End: 2019-12-31Target: 911Updated: 2017-06-20

Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer

CompletedNCT03195192

Side-Out FoundationMetastatic Breast Cancer

Start: 2017-03-09End: 2020-06-30Updated: 2020-07-01

Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression

University of SouthamptonColorectal Cancer

Start: 2008-10-10End: 2025-10-10Target: 1000Updated: 2017-10-13

Biomarker Study to Evaluate Correlations Between Epigenetic Aging and NAD+ Levels in Healthy Volunteers

SuspendedNCT04220658

Elysium HealthEpigenetics

Start: 2019-12-19End: 2023-12-03Target: 170Updated: 2023-02-15

Related Papers

Abstract PS5-28: Multiomic advanced diagnostics for CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast cancer

Cancer Research2021-02-151 citations

CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast cancer for treatment selection and response prediction.

Journal of Clinical Oncology2020-05-201 citations

Abstract 3290: The Side-Out Foundation Metastatic Breast Cancer Database, an open-access portal for multi-omic molecular data and more

Cancer Research2018-07-01